Cambridgeshire and Peterborough
Formulary Chapter 2: Cardiovascular system -
Local Process for warfarin to DOAC switch_April 2020
DOAC Counselling Checklist
National Guidance: Warfarin to DOAC switching _ April 2020
Warfarin to DOAC switching _ Local Guidance _ April 2020
NICE CG187: Acute heart failure: diagnosis and management
UKMI: MI - secondary prevention - Summary of NICE guidance (CG172)
Potassium-sparing diuretics with other diuretics
(furosemide / amiloride)
October 2020 - Supply Issues with Co-amilofruse 5/40 tablets
Milpharm and Sanofi (Frumil) are out of stock until week commencing 19 October and late December 2020, respectively.
Supplies remain available from Wockhardt.
at all other Trusts
MHRA Drug Safety update: Hydrochlorothiazide - risk of non-melanoma skin cancer, particularly in long-term use
(triamterene / hydrochlorothiazide)
at all other Trusts
MHRA Drug Safety Update: Hydrochlorothiazide - risk of non-melanoma skin cancer, particularly in long-term use
Non Formulary Items
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
Available Over the Counter. Consider Self Care
Formulary - Can be prescribed in both secondary and primary care.
Formulary - Specialist Advice, secondary care advice provided for primary care initiation.
Formulary - Specialist initiation without shared care guidance.
Formulary - Specialist initiation with shared care guidance.
Restricted - Hospital only, not to be prescribed in primary care.
Not recommended for prescribing. Switch to alternative cost-effective option.
Not recommended for prescribing in primary or secondary care.
Not recommended as no formal application made for addition to the formulary. Contact relevant pharmacy team for further information.
Non-Formulary (category under review).